Comments on Draft Guidance: “Rare Diseases: Common Issues in Drug Development” October 16, 2015 Share this page Rare disease drug development presents a variety of unique and at times, daunting challenges which may require significant guidance to overcome Related Articles A Mid-Year State Policy Recap July 22, 2026 The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 FDA Rare Disease Roundtable – June 3, 2026 June 04, 2026 See All News